Sinomune Pharmaceutical

Wuxi, China · Founded 1999 · Privately Held (backing)

Developer and manufacturer of pharmaceutical drugs with clinical value intended to specialize in the area of dermatology and nephrology. Sinomune Pharmaceutical is based in Wuxi, China and was founded in 1999. Its last reported valuation was $300 million in Aug 2021. It has raised $64.4 million.

Last reported valuation
$300.5M
Oct 2026
Priced at
—
Total raised
$64.4M
Last round
—

Who backs Sinomune Pharmaceutical?

8 investors
InvestorType
Jolmo InvestmentVenture capital
Wuxi CapitalOther
Sinovation VenturesOther
Cathay CapitalPE / buyout
Wuxi Capital GroupOther
Wuxi Jinkong Qiyuan InvestmentOther
Hubei High-tech Industry Investment Group—
Wenzhou Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Sinomune Pharmaceutical investors

8 investors are on record for Sinomune Pharmaceutical, including Jolmo Investment, Wuxi Capital, Sinovation Ventures and Cathay Capital.

Free account
More of Sinomune Pharmaceutical with a free account
  • ·Watch Sinomune Pharmaceutical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Sinomune Pharmaceutical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View